Literature DB >> 11007824

Renal function of children exposed to cyclosporin in utero.

P L Giudice1, L Dubourg, A Hadj-Aïssa, M H Saïd, O Claris, P Audra, X Martin, P Cochat.   

Abstract

BACKGROUND: The use of cyclosporin (CsA) has improved graft survival in transplant (Tx) patients despite its potential nephrotoxicity. Children born to transplanted women may present with intrauterine growth retardation (IUGR). On the basis of potential reduced nephron mass both in IUGR and in newborn experimental animals exposed to CsA in utero, we investigated the renal function of children >1 year of age born to women under maintenance immunosuppression, including CsA.
METHODS: Fourteen children born to 12 Tx women (nine kidney, one pancreas-kidney, one heart, one liver) were investigated using inulin clearance (C(in)), para-aminohippuric acid clearance (C(PAH)), microalbuminuria, and electrolyte reabsorption rate.
RESULTS: Gestational age of the 14 infants was 34+/-3 weeks and birth weight 2018+/-620 g. During pregnancy, CsA trough blood level was 234+/-115 microg/l and plasma creatinine range was 96-136 micromol/l. Two children were excluded from the study because renal investigation led to a diagnosis of hereditary nephritis (one Alport syndrome, one familial dominant focal segmental glomerulosclerosis) that was retrospectively completed in the mother. Renal function tests were finally performed in 12 children at 2.6+/-1.8 years of age: BP 94+/-7/55+/-5 mmHg, C(in) 117+/-28 ml/min/1.73 m(2), C(PAH) 545+/-124 ml/min/1.73 m(2), filtration fraction 0.23+/-0.03, microalbuminuria 4.2+/-3.5 mg/mmol. Electrolyte tubular reabsorption rates and urine concentrating capacity were normal.
CONCLUSION: These results suggest that in children born to transplanted women taking CsA, renal function develops normally despite prolonged exposure in utero.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007824     DOI: 10.1093/ndt/15.10.1575

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

Review 1.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Pharmacological Approach to Managing Childhood-Onset Systemic Lupus Erythematosus During Conception, Pregnancy and Breastfeeding.

Authors:  Nicole Bitencourt; Bonnie L Bermas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

Review 3.  Pregnancy and renal failure: the case for application of dosage guidelines.

Authors:  F Keller; M Griesshammer; U Häussler; W Paulus; A Schwarz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients.

Authors:  Cameron J McKinzie; Jillian P Casale; Jack C Guerci; Alyson Prom; Christina T Doligalski
Journal:  Paediatr Drugs       Date:  2022-07-23       Impact factor: 3.930

5.  Growth of children born to renal transplanted women.

Authors:  M Isabel S Dinelli; Erika Ono; Patrícia O Viana; Amélia M N Dos Santos; M Isabel de Moraes-Pinto
Journal:  Eur J Pediatr       Date:  2017-07-18       Impact factor: 3.183

6.  Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery.

Authors:  Ching-Pin Chang; Bradley W McDill; Joel R Neilson; Heidi E Joist; Jonathan A Epstein; Gerald R Crabtree; Feng Chen
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

7.  Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant.

Authors:  Irena Nulman; Michael Sgro; Maru Barrera; David Chitayat; John Cairney; Gideon Koren
Journal:  Paediatr Drugs       Date:  2010-04-01       Impact factor: 3.022

Review 8.  Immunosuppression in pregnancy: choices for infant and maternal health.

Authors:  Vincent T Armenti; Michael J Moritz; Elyce H Cardonick; John M Davison
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 9.  Ciclosporin use during pregnancy.

Authors:  Karolina Paziana; Magaly Del Monaco; Elyce Cardonick; Michael Moritz; Matthew Keller; Bruce Smith; Lisa Coscia; Vincent Armenti
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

10.  Use of cyclosporine in uterine transplantation.

Authors:  Srdjan Saso; Karl Logan; Yazan Abdallah; Louay S Louis; Sadaf Ghaem-Maghami; J Richard Smith; Giuseppe Del Priore
Journal:  J Transplant       Date:  2011-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.